Ionis Pharmaceuticals
IONS
IONS
311 hedge funds and large institutions have $4.69B invested in Ionis Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 87 increasing their positions, 126 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 336 → 311 (-25)
31% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 126
36% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 53
Holders
311
Holding in Top 10
5
Calls
$17.2M
Puts
$10.2M
Top Buyers
| 1 | +$58.2M | |
| 2 | +$51.4M | |
| 3 | +$49.5M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$26.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.3M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$17.9M | |
| 3 | -$14.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12.8M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$12.5M |